2 results
Approved WMOCompleted
The primary objectives are to establish dose-response relationship for 2% transdermal testosterone (TostranĀ®) gel to achieve total testosterone serum concentrations between 1.5-2.5 nmol/l in transgender women after vaginoplasty and to assess sideā¦
Approved WMOCompleted
To compare the pharmacokinetics of sublingual testosterone cyclodextrin followed by buspirone as an encapsulated tablet with administration of testosterone and buspirone as one tablet designed to release the components in a specific time-frame.